Report Titile :- Controlled Release Drug Delivery Market is Anticipated to Reach US$ 71.2 BN by 2026, Growing at a CAGR of over 14.3% until 2026 Increasing technology penetration in the healthcare sector is driving the demand for global controlled release drug delivery market The global controlled release drug delivery market size is anticipated to around USD 91.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period. Surge in technological penetration in healthcare sector is expected to drive the growth of the global controlled release drug delivery market. Also, increased patient engagement and awareness of technology are anticipated to boot the market over the forthcoming years. Soaring demand for pediatric and geriatric controlled release delivery methods and substitute therapies and increasing consciousness about advantages of these systems over conventional forms are providing a fillip to the controlled release drug delivery market market. These technologies deliver numerous advantages over old-style delivery forms. Uniform drug effect, reduced dosage and less gastrointestinal side effects, dosage frequency, enhanced patient compliance, improved drug efficacy & safety, and reduced fluctuation of plasma drug levels are some of the advantages delivered by these technologies. Request a Sample Copy of Controlled Release Drug Delivery Market@ https://www.acumenresearchandconsulting.com/request-sample/981 Increase in acceptance of advance and improvised healthcare gadgets are the other reason for the development of the global controlled release drug delivery market. Apart from this
various features such as timely delivery of drug is another factor triggering the market development. Increasing awareness concerning the antagonistic effects of non-adherence is calculable to surge the controlled unharness drug delivery trade growth. Awareness relating to the advantages of connected systems over the standard systems is additionally anticipated to drive the controlled unharness drug delivery market growth across the world over the approaching years. The global controlled release drug delivery market is bifurcated into four major segment named application, release mechanism, technology, and region. On the basis of the application the global controlled release drug delivery market is segmented into metered dose inhalers, injectable, transdermal and ocular patches, infusion pumps, oral controlleddrug delivery systems, and drug eluting stents. On the basis of release mechanism the controlled release drug delivery market is segmented into Polymer based systems, micro reservoir partition controlled drug delivery systems, feedback regulated drug delivery systems, and activation-modulated drug delivery systems, and chemically activated.These activation-modulated drug delivery systems are further bifurcated into osmotic pressure activated, hydrodynamic pressure activated, vapor pressure activated, mechanically activated, and magnetically activated. The chemically activated is also further segmented into ph activated, hydrolysis activated, and enzyme activated.On the basis of technology, the controlled release drug delivery market is segmented into wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery, and others. On the basis of region the global controlled release drug delivery market is segmented into Asia Pacific, North America, Latin America Europe, and Middle East & Africa. Browse Full Report with Table of Content, List of Table and Figures@ https://www.acumenresearchandconsulting.com/controlled-release-drugdelivery-market Controlled release drug delivery systems permit reduction in quantity of dose and dose frequency, increased patient compliance and acceptance, less fluctuation in plasma drug levels, uniform drug result, and improved effectualness quantitative relation of administered therapeutic. as compared to traditional delivery, these systems accomplish a chronic therapeutic result, increase foregone conclusion in drug unleash dynamics, and produce concerning delivery at a pre-determined rate regionally or consistently. Thus, with many more blessings offered by these systems, their adoption is slated to extend at a motivating rate over the approaching years. North America captures the largest revenue share at 35.6% and will continue to retain its dominance position over the forthcoming years. Speedy acceptance of advanced devices and technologies and high per capita healthcare expenditure are expected to surge the need for connected drug delivery systems in the region. High price of controlled release drug delivery is expected to be the one of the substantial factor in hampering the market growth in emerging regions such as MEA, APAC and Latin America. Though, with the growing
numeral of market entrants the device prices are anticipated to fall over time; this will backing the market growth in emerging such countries such as India and China. The key players operating in the global controlled release drug delivery market are Capsugel, Orbis Biosciences, Inc., Pfizer, Inc, Merck and Co., Inc., Johnson and Johnson, Alkermes plc, Coating Place, Inc., Depomed, Inc., Corium International, Inc., and Aradigm Corporation. These market participants are investing enormous wealth to revolutionise the product line as the rivalry in the market is growing with rapid pace. Likewise, with varying technology the demand for better healthcare infrastructures are growing, so cater the demand of the customers, market participants are continuously inventing new products. TABLE OF CONTENT CHAPTER 1. INDUSTRY OVERVIEW 1.1. Definition and Scope 1.1.1. Definition of Controlled Release Drug Delivery 1.1.2. Market Segmentation 1.1.3. List of Abbreviations 1.2. Summary 1.2.1. Market Snapshot 1.2.2. Controlled Release Drug Delivery Market By Release Mechanism 1.2.2.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison By Release Mechanism (2015-2026) 1.2.2.2. Global Controlled Release Drug Delivery Market Revenue Share By Release Mechanism in 2017 1.2.2.3. Polymer Based Systems 1.2.2.4. Micro Reservoir Partition Controlled Drug Delivery Systems 1.2.2.5. Feedback Regulated Drug Delivery Systems 1.2.2.6. Activation-modulated Drug Delivery Systems 1.2.2.7. Chemically Activated 1.2.2.8. Others 1.2.3. Controlled Release Drug Delivery Market By Technology 1.2.3.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison By Technology (2015-2026) 1.2.3.2. Wurster Technique 1.2.3.3. Coacervation 1.2.3.4. Micro Encapsulation 1.2.3.5. Implants 1.2.3.6. Transdermal 1.2.3.7. Targeted Delivery 1.2.3.8. Others 1.2.4. Controlled Release Drug Delivery Market By Application 1.2.4.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate
Comparison By Application (2015-2026) 1.2.4.2. Metered Dose Inhalers 1.2.4.3. Injectable 1.2.4.4. Transdermal and Ocular Patches 1.2.4.5. Infusion Pumps 1.2.4.6. Oral Controlled-drug delivery Systems 1.2.4.7. Drug Eluting Stents 1.2.4.8. Others 1.2.5. Controlled Release Drug Delivery Market by Geography 1.2.5.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison by Geography (2015-2026) 1.2.5.2. North America Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026) 1.2.5.3. Europe Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026) 1.2.5.4. Asia-Pacific Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026) 1.2.5.5. Latin America Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026) 1.2.5.6. Middle East and Africa (MEA) Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026) CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS 2.1. Market Drivers 2.2. Restraints and Challenges 2.3. Growth Opportunities 2.4. Porter’s Five Forces Analysis 2.4.1. Bargaining Power of Suppliers 2.4.2. Bargaining Power of Buyers 2.4.3. Threat of Substitute 2.4.4. Threat of New Entrants 2.4.5. Degree of Competition 2.5. Value Chain Analysis 2.6. Cost Structure Analysis 2.6.1. Raw Material and Suppliers 2.6.2. Manufacturing Process Analysis 2.7. Regulatory Compliance 2.8. Competitive Landscape, 2017 2.8.1. Player Positioning Analysis 2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS 3.1. Capacity and Commercial Production Date of Global Controlled Release Drug Delivery Major Manufacturers in 2017 3.2. Manufacturing Plants Distribution of Global Controlled Release Drug Delivery Major Manufacturers in 2017 3.3. R&D Status and Technology Source of Global Controlled Release Drug Delivery Major Manufacturers in 2017 3.4. Raw Materials Sources Analysis of Global Controlled Release Drug Delivery Major Manufacturers in 2017 CHAPTER 4. CONTROLLED RELEASE DRUG DELIVERY MARKET BY RELEASE MECHANISM 4.1. Global Controlled Release Drug Delivery Revenue By Release Mechanism 4.2. Polymer Based Systems 4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.3. Micro Reservoir Partition Controlled Drug Delivery Systems 4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.4. Feedback Regulated Drug Delivery Systems 4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.5. Activation-modulated Drug Delivery Systems 4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.6. Chemically Activated 4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.7. Other 4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 5. CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY 5.1. Global Controlled Release Drug Delivery Revenue By Technology 5.2. Wurster Technique 5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.3. Coacervation 5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.4. Micro Encapsulation
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.5. Implants 5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.6. Transdermal 5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.7. Targeted Delivery 5.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.8. Others 5.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 6. CONTROLLED RELEASE DRUG DELIVERY MARKET BY APPLICATION 6.1. Global Controlled Release Drug Delivery Revenue By Application 6.2. Metered Dose Inhalers 6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.3. Injectable 6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.4. Transdermal and Ocular Patches 6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.5. Infusion Pumps 6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.6. Oral Controlled-drug delivery Systems 6.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.7. Drug Eluting Stents 6.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.8. Others 6.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 7. NORTH AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY 7.1. North America Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.2. North America Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%) 7.3. U.S. 7.3.1. U.S. Controlled Release Drug Delivery Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 7.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 7.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 7.4. Canada 7.4.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 7.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 7.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 7.5. Mexico 7.5.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 7.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 7.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 8. EUROPE CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY 8.1. Europe Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 – 2026 ($Million) 8.2. Europe Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%) 8.3. UK 8.3.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 8.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 8.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 8.4. Germany 8.4.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 8.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 8.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 8.5. France 8.5.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 8.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 8.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 8.6. Spain 8.6.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 8.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 8.6.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 8.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 8.7.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 9. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY 9.1. Asia-Pacific Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 – 2026 ($Million) 9.2. Asia-Pacific Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%) 9.3. China 9.3.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 9.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 9.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.4. Japan 9.4.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 9.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 9.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.5. India 9.5.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 9.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 9.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.6. Australia 9.6.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 9.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 9.6.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.7. South Korea 9.7.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 9.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 9.7.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.8. Rest of Asia-Pacific 9.8.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 9.8.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 9.8.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 10. LATIN AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY 10.1. Latin America Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 – 2026 ($Million) 10.2. Latin America Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%) 10.3. Brazil 10.3.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 10.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 10.4. Argentina 10.4.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 10.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 10.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 10.5. Rest of Latin America 10.5.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 10.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 10.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 11. MIDDLE EAST CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY 11.1. Middle East Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 – 2026 ($Million) 11.2. Middle East Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%) 11.3. Saudi Arabia 11.3.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 11.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 11.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 11.4. UAE 11.4.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 11.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 11.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 11.5. Rest of Middle East 11.5.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 11.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 11.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 12. AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY 12.1. Africa Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 – 2026 ($Million) 12.2. Africa Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%) 12.3. South Africa 12.3.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 12.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 12.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 12.4. Egypt 12.4.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 12.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 12.5. Rest of Africa 12.5.1. Market Revenue and Forecast By Release Mechanism, 2015 – 2026 ($Million) 12.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million) 12.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 13. COMPANY PROFILE 13.1. Capsugel 13.1.1. Company Snapshot 13.1.2. Overview 13.1.3. Financial Overview 13.1.4. Type Portfolio 13.1.5. Key Developments 13.1.6. Strategies 13.2. Orbis Biosciences, Inc. 13.2.1. Company Snapshot 13.2.2. Overview 13.2.3. Financial Overview 13.2.4. Type Portfolio 13.2.5. Key Developments 13.2.6. Strategies 13.3. Pfizer, Inc 13.3.1. Company Snapshot 13.3.2. Overview 13.3.3. Financial Overview 13.3.4. Type Portfolio 13.3.5. Key Developments 13.3.6. Strategies 13.4. Merck and Co., Inc. 13.4.1. Company Snapshot 13.4.2. Overview 13.4.3. Financial Overview 13.4.4. Type Portfolio 13.4.5. Key Developments 13.4.6. Strategies 13.5. Johnson and Johnson 13.5.1. Company Snapshot 13.5.2. Overview 13.5.3. Financial Overview 13.5.4. Type Portfolio 13.5.5. Key Developments 13.5.6. Strategies 13.6. Alkermes plc 13.6.1. Company Snapshot 13.6.2. Overview
13.6.3. Financial Overview 13.6.4. Type Portfolio 13.6.5. Key Developments 13.6.6. Strategies 13.7. Coating Place, Inc. 13.7.1. Company Snapshot 13.7.2. Overview 13.7.3. Financial Overview 13.7.4. Type Portfolio 13.7.5. Key Developments 13.7.6. Strategies 13.8. Depomed, Inc. 13.8.1. Company Snapshot 13.8.2. Overview 13.8.3. Financial Overview 13.8.4. Type Portfolio 13.8.5. Key Developments 13.8.6. Strategies 13.9. Corium International, Inc. 13.9.1. Company Snapshot 13.9.2. Overview 13.9.3. Financial Overview 13.9.4. Type Portfolio 13.9.5. Key Developments 13.9.6. Strategies 13.10. Aradigm Corporation 13.10.1. Company Snapshot 13.10.2. Overview 13.10.3. Financial Overview 13.10.4. Type Portfolio 13.10.5. Key Developments 13.10.6. Strategies 13.11. Others 13.11.1. Company Snapshot 13.11.2. Overview 13.11.3. Financial Overview 13.11.4. Type Portfolio 13.11.5. Key Developments 13.11.6. Strategies CHAPTER 14. RESEARCH APPROACH 14.1. Research Methodology 14.1.1. Initial Data Search 14.1.2. Secondary Research
14.1.3. Primary Research 14.2. Assumptions and Scope The report is readily available and can be dispatched immediately after payment confirmation. To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/981 Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157 Browse More Press Releases: https://healthcareandpharmaceuticals.wordpress.com